AB044. SOH23ABS_117. Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor positive breast cancer: a systematic review and network meta-analysis
Mesentery and peritoneum(2023)
Abstract
Background: The OncotypeDX© 21-gene Recurrence Score (RS) estimates the risk of distant-disease recurrence in early-stage estrogen receptor positive, human epidermal growth factor receptor-2 negative (ER+/HER2−) breast cancer. Using RS to estimate risk of locoregional recurrence (LRR) is less conclusive. We aimed to perform network meta-analysis (NMA) evaluating the RS in estimating LRR in ER+/HER2− breast cancer.
MoreTranslated text
Key words
estrogen receptor,positive breast cancer,breast cancer,meta-analysis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined